RAPT Therapeutics, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises Youdao, Inc. on Its Initial Public Offering, NYSE Listing and Concurrent Private Placements
Davis Polk advised Youdao, Inc. on its SEC-registered initial public offering of 5,600,000 American Depositary Shares. Each ADS represents one Class A ordinary share of Youdao. Youdao has…
Datadog, Inc. $648 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $648 million initial public offering by Datadog, Inc. of 24,000,000 shares of its Class A common stock. The Class A common stock…
Davis Polk Advises the Goldman Sachs Merchant Banking Division on Its Investment in MedVet
Davis Polk is advising the Goldman Sachs Merchant Banking Division in connection with its investment in MedVet.
Founded in 1869, The Goldman Sachs Group, Inc. is a leading global investment…
Zynga $690 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Zynga Inc. of $690 million aggregate principal amount of its 0.25% convertible senior notes due 2024,…
Cornell Capital’s Corelle Brands to merge with Instant Brands
Davis Polk is advising Cornell Capital LLC on the merger of its portfolio company, Corelle Brands LLC, with Instant Brands, Inc. The transaction is expected to close by the end of the…
8x8, Inc. $287.5 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by 8x8, Inc. of $287.5 million aggregate principal amount of its 0.50% convertible…
$4.58 Billion Financing for CC Capital’s Acquisition of The Dun & Bradstreet Corporation
Davis Polk advised the administrative agent, joint lead arrangers, joint bookrunners and senior managing agents, with respect to The Dun & Bradstreet Corporation’s $2.53 billion senior…
Davis Polk Advises AC Immune SA on Its $117.5 Million Follow-On Public Offering and Subscription Rights Offerings
Davis Polk advised AC Immune SA in connection with its $117.5 million U.S. follow-on public offering. AC Immune sold 8,500,000 of its newly issued common shares and subscription rights…